Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald J Gleich

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|June 13, 2009
Anti-interleukin-5 therapy and severe asthmaGerald J Gleich
Blood|August 4, 2018
Dexpramipexole: a new antieosinophil drug?Gerald J Gleich
The Journal of Allergy and Clinical Immunology. in Practice|October 13, 2023
Episodic angioedema associated with eosinophilia: Benralizumab-induced complete remissionGerald J Gleich, Richard Hendershot
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Allergic rhinitis and asthma induced by boxelder bug sensitizationJamie Zussman, Gerald J Gleich
Oncology (Williston Park, N.Y.)|April 24, 2009
Anaphylaxis: implications of monoclonal antibody use in oncologyGerald J Gleich, Kristin M Leiferman
Journal of Leukocyte Biology|June 26, 2024
The true extent of eosinophil involvement in disease is unrecognized: the secret life of dead eosinophilsKristin M Leiferman, Gerald J Gleich
The Journal of Allergy and Clinical Immunology|January 10, 2004
Hypereosinophilic syndrome: case presentation and updateKristin M Leiferman, Gerald J Gleich
The Journal of Allergy and Clinical Immunology|May 4, 2010
What targeting eosinophils has taught us about their role in diseasesBruce S Bochner, Gerald J Gleich
Current Opinion in Immunology|October 11, 2005
The hypereosinophilic syndromes: still more heterogeneityGerald J Gleich, Kristin M Leiferman
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2022
Does Eosinophil Depletion in Gastroenteric Diseases Associated With the Hypereosinophilic Syndrome Teach Us Whether Normal Humans Need Eosinophils in 2022?Gerald J Gleich, Kristin M Leiferman
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|June 13, 2009
Anti-interleukin-5 therapy and severe asthmaGerald J Gleich
Blood|August 4, 2018
Dexpramipexole: a new antieosinophil drug?Gerald J Gleich
The Journal of Allergy and Clinical Immunology. in Practice|October 13, 2023
Episodic angioedema associated with eosinophilia: Benralizumab-induced complete remissionGerald J Gleich, Richard Hendershot
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Allergic rhinitis and asthma induced by boxelder bug sensitizationJamie Zussman, Gerald J Gleich
Oncology (Williston Park, N.Y.)|April 24, 2009
Anaphylaxis: implications of monoclonal antibody use in oncologyGerald J Gleich, Kristin M Leiferman
Journal of Leukocyte Biology|June 26, 2024
The true extent of eosinophil involvement in disease is unrecognized: the secret life of dead eosinophilsKristin M Leiferman, Gerald J Gleich
The Journal of Allergy and Clinical Immunology|January 10, 2004
Hypereosinophilic syndrome: case presentation and updateKristin M Leiferman, Gerald J Gleich
The Journal of Allergy and Clinical Immunology|May 4, 2010
What targeting eosinophils has taught us about their role in diseasesBruce S Bochner, Gerald J Gleich
Current Opinion in Immunology|October 11, 2005
The hypereosinophilic syndromes: still more heterogeneityGerald J Gleich, Kristin M Leiferman
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2022
Does Eosinophil Depletion in Gastroenteric Diseases Associated With the Hypereosinophilic Syndrome Teach Us Whether Normal Humans Need Eosinophils in 2022?Gerald J Gleich, Kristin M Leiferman
Pageof 11